The Influence of Topical Diclofenac Sodium on the Ocular Hypotensive Effect of Latanoprost in Glaucoma Patients

PurposeTo evaluate the effect of diclofenac sodium 0.1% on reducing intraocular pressure (IOP) by latanoprost 0.005% in glaucoma patients. Patients and MethodsTwenty-two patients with bilateral primary open angle glaucoma were enrolled in this study. All patients had been given only latanoprost for at least 4 weeks. Topical diclofenac sodium was additionally applied to one eye (dicloptin group), whereas hydroxypropyl methyl cellulose was administered into the other eye (control group); both 4 times a day for 2 weeks. IOP measurement was performed before and 2 weeks after the administrations, and also 2 weeks after discontinuing additional ophthalmic solutions. ResultsNo significant difference was observed in the IOPs before additional administration of ophthalmic solution between the dicloptin group and the control group (P=0.47). Additional administration of diclofenac sodium increased mean IOP from 15.73±1.75 to 17.32±2.23 mm Hg (P=0.01). This increase was reversed 2 weeks after discontinuing additional solutions (P=0.80); however, no significant difference in mean IOP was observed in the control group after administration and after discontinuing the additional medication (P=0.94 and 0.84, respectively). ConclusionsTopical diclofenac sodium may interfere with the IOP lowering effect of latanoprost in glaucoma patients; therefore this interference should be noted in coadministration of these drugs.

[1]  G. Georgopoulos,et al.  Efficacy and safety of latanoprost in eyes with uveitic glaucoma , 2009, Graefe's Archive for Clinical and Experimental Ophthalmology.

[2]  L. Rossetti,et al.  Efficacy of the Fixed Combinations of Bimatoprost or Latanoprost plus Timolol in Patients Uncontrolled with Prostaglandin Monotherapy: A Multicenter, Randomized, Investigator-Masked, Clinical Study , 2009, European journal of ophthalmology.

[3]  F. Parmeggiani,et al.  Topical and Oral Ketorolac Administration Increases the Intraocular Pressure-Lowering Effect of Latanoprost , 2008, Current eye research.

[4]  A. Alm.  Can NSAIDs and prostaglandin analogues be combined? , 2006, British Journal of Ophthalmology.

[5]  T. Matsuo.  Prostaglandins F2α and E2 in Aqueous Humor of Patients with Cataract Surgery , 2004 .

[6]  K. Kashiwagi,et al.  Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost , 2003, The British journal of ophthalmology.

[7]  R. Schalnus.  Topical Nonsteroidal Anti-Inflammatory Therapy in Ophthalmology , 2003, Ophthalmologica.

[8]  Sarah J Miller,et al.  Prostaglandin Analog Treatment of Glaucoma and Ocular Hypertension , 2002, The Annals of pharmacotherapy.

[9]  F. Shen,et al.  Effect of Pilocarpine 4% in Combination With Latanoprost 0.005% or 8-iso Prostaglandin E2 0.1% on Intraocular Pressure in Laser-induced Glaucomatous Monkey Eyes , 2001, Journal of glaucoma.

[10]  J. J. Moreno.  Arachidonic acid release and prostaglandin E2 synthesis as irritant index of surfactants in 3T6 fibroblast cultures. , 2000, Toxicology.

[11]  A. Alm,et al.  Acetylsalicylic acid does not reduce the intraocular pressure variation in ocular hypertension or glaucoma. , 2000, Experimental eye research.

[12]  I. Ota,et al.  Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias. , 1999, Archives of ophthalmology.

[13]  S. Podos,et al.  Effect of 8-iso prostaglandin E2 on aqueous humor dynamics in monkeys. , 1998, Archives of ophthalmology.

[14]  J. Bullock,et al.  Cystoid macular edema and anterior uveitis associated with latanoprost use. Experience and incidence in a retrospective review of 94 patients. , 1998, Ophthalmology.

[15]  R. Weinreb,et al.  Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. , 1997, Investigative ophthalmology & visual science.

[16]  R. Weinreb,et al.  Prostaglandins alter extracellular matrix adjacent to human ciliary muscle cells in vitro. , 1997, Investigative ophthalmology & visual science.

[17]  A. Alm,et al.  Initial clinical studies with prostaglandins and their analogues. , 1997, Survey of ophthalmology.

[18]  L. Bito.  Prostaglandins: a new approach to glaucoma management with a new, intriguing side effect. , 1997, Survey of ophthalmology.

[19]  R. Weinreb,et al.  Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: implications for uveoscleral outflow. , 1997, Survey of ophthalmology.

[20]  Z. Ye,et al.  Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species. , 1996, Experimental eye research.

[21]  J. Stjernschantz,et al.  A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group. , 1996, Ophthalmology.

[22]  O. Hayaishi,et al.  Prostaglandin D2 reduces intraocular pressure. , 1988, The British journal of ophthalmology.

[23]  A. Flach,et al.  Topical prostaglandin E2 effects on normal human intraocular pressure. , 1988, Journal of ocular pharmacology.